ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,294Medicare Part D Prescriptions Filled, Including Refills

Rank: 163 out of 680

$617K Total Retail Price of All Prescriptions

Rank: 207 out of 680

382 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 382 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

46% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 5,401 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
HYDROCODONE-ACETAMINOPHEN 1,220 442 S3 1 4
LISINOPRIL 409 214 2 5
AMLODIPINE BESYLATE 378 188 3 1
LEVOTHYROXINE SODIUM 360 208 4 2
METOPROLOL TARTRATE 350 189 5 12
NEXIUM 343 139 6 16
SIMVASTATIN 332 172 7 3
FUROSEMIDE 296 158 8 6
ZOLPIDEM TARTRATE 269 99 9 17
TRAMADOL HCL 264 130 10 18
OMEPRAZOLE 262 105 11 7
METFORMIN HCL 256 142 12 8
HYDROCHLOROTHIAZIDE 235 111 13 9
SERTRALINE HCL 179 87 14 28
METOPROLOL SUCCINATE 150 81 15 13
GABAPENTIN 146 60 16 15
GLIMEPIRIDE 141 63 17 29
RANITIDINE HCL 131 37 18 56
CARISOPRODOL 127 16 R 19 83
PROMETHAZINE HCL 126 19 R 20 96
CARVEDILOL 123 61 21 23
CLOPIDOGREL 114 69 22 26
PROAIR HFA 112 35 23 67
ROPINIROLE HCL 107 45 24 99
PRAVASTATIN SODIUM 105 61 25 10
MELOXICAM 102 65 26 24
AMITRIPTYLINE HCL 98 43 R 27 47
POTASSIUM CHLORIDE 96 55 28 14
IBUPROFEN 88 18 29 126
PLAVIX 87 64 30 39
ADVAIR DISKUS 87 25 30 53
ESTRADIOL 87 22 R 30 134
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 36 33 94
AMOXICILLIN 81 31 34 111
CYMBALTA 80 24 35 46
VENTOLIN HFA 76 21 36 202
ATORVASTATIN CALCIUM 75 44 37 11
CLONIDINE HCL 73 27 38 36
QUINAPRIL HCL 71 50 39 104
TAMSULOSIN HCL 71 34 39 34
ALPRAZOLAM 69 34 41 72
PREDNISONE 65 36 42 50
BENAZEPRIL HCL 63 38 43 40
WARFARIN SODIUM 63 32 43 20
CITALOPRAM HBR 57 0 45 22
CYCLOBENZAPRINE HCL 56 0 R 46 81
GLYBURIDE 56 17 R 46 85
QUETIAPINE FUMARATE 55 19 48 64
PANTOPRAZOLE SODIUM 53 38 49 30
CLONAZEPAM 53 0 49 190
FAMOTIDINE 51 37 51 89
AMOX TR-POTASSIUM CLAVULANATE 51 19 51 124
TRICOR 50 24 53 98
TRAZODONE HCL 50 20 53 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.